Work

CB1 receptor inverse agonist pharmacotherapy for metabolic disorders

Year: 2009

Type: article

Source: Drug Development Research

DOI: 10.1002/ddr.20335

Authors: Tung M. Fong, Carol Addy, Ngozi Erondu, Steven B. Heymsfield

Institution: Merck & Co., Inc., Rahway, NJ, USA (United States)

Language: English

Topic: Cannabis and Cannabinoid Research

Subfield: Pharmacology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2082427099

FWCI: 0.239

Cites: 70

Cited by: 2

Related to: 10